In the β-TCP Bioceramic Bone Graft Substitutes segmentation by application, four clinical domains capture the bulk of demand: orthopedic trauma, spinal fusion, dental implantation, and craniofacial reconstruction. Orthopedic trauma, encompassing long‑bone fractures, segmental defects, and non‑unions, represents the largest slice—approximately 40 % of global sales—driven by high procedure volumes and the material’s proven load‑sharing capacity. Spinal fusion procedures, particularly lumbar interbody fusion, account for about 30 % of the market; β‑TCP’s osteoconductive scaffold facilitates vertebral body remodeling while limiting donor‑site morbidity. Dental applications, including alveolar ridge augmentation and sinus lift, contribute roughly 20 % of revenue, reflecting steady growth in implant dentistry and the material’s compatibility with guided bone regeneration protocols. Craniofacial reconstruction, which involves maxillofacial defects and pediatric cranial vault remodeling, remains a smaller but strategically important segment at 10 %, supported by the material’s resorbability and ease of contouring. These application‑specific shares are reflected in the accompanying pie‑chart, illustrating how procedural prevalence and reimbursement structures dictate the overall market composition.
